Eve Sleep Plc (EVE.L) Announced that the company is in very early stage discussions regarding a potential merger with Simba Ltd (Simba), structured by way of the acquisition of Simba by the company. There can be no certainty that the potential transaction will proceed or certainty as to the terms of the potential transaction.
RNS Number: 6291 I AIM 12 August 2019. TEMPORARY SUSPENSION OF TRADING ON AIM. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Eve Sleep plc: Statement Regarding Recent Press Speculation and Temporary Suspension of Trading.
RNS Number: 3296 G eve Sleep plc 22 July 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3285 G eve Sleep plc 22 July 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Eve Sleep Plc (EVE.L) Announced, in its trading update for the six months ended 30 June 2019, that the company made good progress in reducing EBITDA losses and improving cash management. In line with Board expectations, the underlying EBITDA loss reduced by 50% to £5.9 million from a loss of £11.9 million in H1 2018, driven by the refocus on just three markets, greater marketing efficiency and a reduction in overheads. Net cash at the end of the period was £12.5 million. Group revenue growth for the year is expected to be second half weighted. UK&I revenues for the period were broadly flat at 0.9% below last year, owing to the planned reduction in H1 marketing investment, as well as the challenging retail backdrop and a highly promotional mattress market. Separately, the company announced the appointment of finnCap Ltd as its Nominated Advisor and Corporate Broker with immediate effect.
Eve Sleep plc: Pre-close trading update.
RNS Number: 8736 F eve Sleep plc 17 July 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 8724 F eve Sleep plc 17 July 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Andrew Hore Quoted #Micro 15 July 2019 #AFHP #HYDP #CFCP #COIN #ESO #KR1 #BEG #MED #TEK #AAU #IKA #MIRA #SOM #POLX #COS #EVE #WEN #FIH #CHAL #BVC #AIM #NEX #LSE #microcaps #smallcaps #stockstowatch #stocksinnews
Eve Sleep plc: Block listing six monthly return.
Eve Sleep plc: Notification of major holdings.
Eve Sleep plc: Standard form for notification of major holdings.
I discuss i3 Energy #I3E Eve Sleep #EVE Catenae Innovation #CTEA and Bidstack #BIDS with Justin on the Vox Markets podcast. The interview starts at 20 minutes 26 seconds.
RNS Number: 0218 E eve Sleep plc 01 July 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Eve Sleep plc: Notification of Trading Update.
Eve Sleep Plc
EVE.L
Eve Sleep Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    260.05M

Income Statement

Sales/Revenue
Gross Income
Operating Income
Net Interest Income
Pre-Tax Income
Consolidated Net Income
Non-Interest Income
Interest Income after Loan Loss Provision
Non-Operating Income
Operating Income (EBIT)
Net Income
Non-Interest Expense
Operating Expenses
Total Expense
Operating profit per share
EPS (Basic)
EPS (Diluted - Before Unusual Expense)
EPS (Fully Diluted)

Balance Sheet - Assets

Net Property, Plant & Equipment
Intangible Assets
Cash & Short Term Investments
Investments
Other Financial Assets
Inventories
Total Short Term Accounts Receivable
Total Accounts Receivable
Total Cash & Due from Banks
Premium Balance Receivables
Total Current Assets
Tangible Other Assets
Other Intangible Assets
Other Assets
Other Funds
Total Assets

Balance Sheet - Liabilities

Liabilities & Stockholders' Equity
Other Current Liabilities
Total Current Liabilities
Provision for Risks & Charges
Losses, Claims & Reserves
Other Liabilities
Total Liabilities

Balance Sheet - Other

Dividends Per Share (Gross)
Dividends Per Share
Dividends Per Share (1-yr Annual Growth)
Dividend payout per share
Common Shares
Common Shares Outstanding
Common Shares (EPS Basic)
Common Shares (EPS Diluted)
Closely Held Shares
Total Shareholders' Equity
Non-Equity Reserves
Retained Earnings
Total Equity
Pre-Tax Margin
Net Interest Margin
Gross Profit Margin
Net Margin
Operating Margin
P/E Ratio
Debt / EBITDA
Total Debt / Assets
Assets Per Employee
Current Ratio
Common Stock Par / Carry Value
Enterprise Value
Market Value
Market Capitalisation
Dividend Yield
Dividend Yield - Security
Cash Dividend Coverage Ratio

Miscellaneous

Total Debt
Restricted Cash
Exchange Rate Effect
Incomes Taxes
Net Change in Cash
Income Tax Payable
Cash Only
Cash Dividends Paid
Convertible Debt
Long Term Debt
Short Term Debt
Asset Turnover
EBITDA
Operating Income After Interest Expense
Net Debt
Operating Income Before Interest Expense
Purchase / Sale of Investments
Other Appropriated Reserves
Creditors
Watchlist